You are here
- Home
- Last 30 days trials
Effects of administration of fostamatinib on blood concentrations of an oral contraceptive in healthy female subjects.
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Mar 9, 2011
- Study Name
- D4300C00012
- Study Id
- D4300C00012
- ClinicalTrials.gov ID
- NCT01276262
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
